Insider Transactions in Q4 2025 at Steris PLC (STE)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2025
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Open market or private sale
|
Direct |
5,036
-18.23%
|
$1,294,252
$257.74 P/Share
|
|
Nov 18
2025
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,536
+24.78%
|
$643,552
$182.22 P/Share
|
|
Nov 11
2025
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Open market or private sale
|
Direct |
15,000
-30.82%
|
$3,975,000
$265.14 P/Share
|
|
Nov 11
2025
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+23.56%
|
$1,035,000
$69.72 P/Share
|
|
Oct 06
2025
|
Daniel A Carestio President and CEO |
SELL
Open market or private sale
|
Direct |
159
-0.31%
|
$38,319
$241.82 P/Share
|
|
Oct 01
2025
|
Mary Clare Fraser SVP & Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-1.58%
|
-
|
|
Oct 01
2025
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
52
-0.48%
|
-
|
|
Oct 01
2025
|
Cary L Majors SVP and President, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
303
-2.21%
|
-
|
|
Oct 01
2025
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
26
-0.36%
|
-
|
|
Oct 01
2025
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.27%
|
-
|
|
Oct 01
2025
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.25%
|
-
|
|
Oct 01
2025
|
Karen L Burton Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,349
+22.05%
|
-
|
|
Oct 01
2025
|
Karen L Burton Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
39
-0.65%
|
-
|